La Jolla, CA, United States of America

Michael Zwick

This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Zwick. Retrieved from https://idiyas.com/inventor/michael-zwick-3gq5lddh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Zwick: Innovator in HIV Vaccine Design

Introduction

Michael Zwick is a prominent inventor based in La Jolla, California. He is known for his significant contributions to the field of vaccine design, particularly in the fight against HIV. His innovative work has the potential to impact global health positively.

Latest Patents

Michael Zwick holds a patent titled "Human Broadly Neutralizing Antibodies Against the Membrane-Proximal External Region of HIV Env for Vaccine Design and Intervention." This patent represents a crucial advancement in the development of effective HIV vaccines.

Career Highlights

Zwick is affiliated with the Scripps Research Institute, where he conducts groundbreaking research. His work focuses on understanding the immune response to HIV and developing strategies to enhance vaccine efficacy.

Collaborations

Michael Zwick collaborates with esteemed colleagues, including Lei Zhang and Adriana Irimia. These partnerships foster a collaborative environment that enhances the research outcomes and accelerates innovation.

Conclusion

Michael Zwick's contributions to HIV vaccine design exemplify the importance of innovation in addressing global health challenges. His work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…